Cyclopentane

Cyclopentane

SCHEMBL5820366

C1CCCC1.CC(C)(C)OC(=O)N1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc([AsH2])n3)s2)CC1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGFR P00533 8/20 0.46
KCNH2 Q12809 4/20 0.46
ACHE P22303 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5819178 0.87 EGFR (0.46) EGFRKCNH2
SCHEMBL5819435 0.87 EGFR (0.48) EGFRKCNH2ACHE
SCHEMBL5820361 0.86 EGFR (0.42) EGFRKCNH2
SCHEMBL5819403 0.85 EGFR (0.43) EGFRKCNH2
SCHEMBL5812894 0.85 EGFR (0.50) EGFRKCNH2ACHE
Cyclohexane SCHEMBL5820492 0.85 GRIA1 (0.47) EGFRKCNH2
SCHEMBL5812942 0.81 EGFR (0.57) EGFRKCNH2
SCHEMBL5819552 0.77 MAPK14 (0.64) EGFRKCNH2
SCHEMBL5818093 0.77 EGFR (0.51) EGFRKCNH2ACHE
SCHEMBL5819594 0.76 EGFR (0.52) EGFRKCNH2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed